Literature DB >> 23384374

Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.

Judith I Tsui1, Debbie M Cheng, Howard Libman, Carly Bridden, Richard Saitz, Jeffrey H Samet.   

Abstract

OBJECTIVE: The purpose of this study was to examine the association between risky drinking amounts and serum aminotransferase levels in HIV-infected adults with and without hepatitis C virus (HCV) infection.
METHOD: In a prospective cohort of HIV-infected adults with current or past alcohol problems, we assessed whether drinking risky amounts (as defined by the National Institute on Alcohol Abuse and Alcoholism) was associated with higher levels of serum aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) over time, stratifying analyses by HCV status. Generalized linear mixed effects regression models were used to examine the association between risky drinking and natural log-transformed AST and ALT over time.
RESULTS: Among HIV/HCV-coinfected persons (n = 200), risky drinking was associated with a higher adjusted mean AST (62.2 vs. 51.4 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.37], p = .003) and ALT (51.3 vs. 41.6 U/L; adjusted ratio of means 1.2, 95% CI [1.07, 1.42], p = .004) compared with non-risky drinking. In contrast, among HIV-infected adults without HCV infection (n = 197), there were no significant differences between those who did and did not drink risky amounts in AST (34.7 vs. 33.3 U/L; adjusted ratio of means = 1.0, 95% CI [0.95, 1.14], p = .36) or ALT (29.1 vs. 28.7 U/L; adjusted ratio of means = 1.0, 95% CI [0.91, 1.13], p = .78).
CONCLUSIONS: Among HIV-infected adults with HCV, those who drink risky amounts have higher serum aminotransferase levels than those who do not drink risky amounts. These results suggest that drinking risky amounts may be particularly harmful in HIV/HCV-coinfected adults and supports recommendations that providers pay special attention to drinking in this population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384374      PMCID: PMC3568165          DOI: 10.15288/jsad.2013.74.266

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  28 in total

Review 1.  Clinical practice. Unhealthy alcohol use.

Authors:  Richard Saitz
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

2.  Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Authors:  Lucy E Wilson; Michael Torbenson; Jacquie Astemborski; Hawazin Faruki; Charles Spoler; Rudra Rai; Shruti Mehta; Gregory D Kirk; Kenrad Nelson; Nezam Afdhal; David L Thomas
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

3.  Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.

Authors:  Matilde Sánchez-Conde; Juan Berenguer; Pilar Miralles; Federico Alvarez; Juan Carlos Lopez; Jaime Cosin; Catalán Pilar; Margarita Ramirez; Isabel Gutierrez; Emilio Alvarez
Journal:  Clin Infect Dis       Date:  2006-07-27       Impact factor: 9.079

4.  Communicating about alcohol consumption to nonharmful drinkers with Hepatitis C: patient and provider perspectives.

Authors:  Carol E Blixen; Noah J Webster; Andrew J Hund; Adam T Perzynski; Stephanie W Kanuch; Eleanor Palo Stoller; Richard A McCormick; Neal V Dawson
Journal:  J Gen Intern Med       Date:  2008-08       Impact factor: 5.128

Review 5.  Noninvasive assessment of liver fibrosis.

Authors:  Stella M Martínez; Gonzalo Crespo; Miquel Navasa; Xavier Forns
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

6.  Psychosocial correlates of alcohol use and reduction for individuals with hepatitis C.

Authors:  Adam T Perzynski; Richard McCormick; Noah J Webster; Carol E Blixen; Stephanie Kanuch; Charles L Thomas; Kevin D Mullen; Neal V Dawson
Journal:  J Stud Alcohol Drugs       Date:  2011-09       Impact factor: 2.582

7.  Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.

Authors:  Lydia N Drumright; Holly Hagan; David L Thomas; Mary H Latka; Elizabeth T Golub; Richard S Garfein; John D Clapp; Jennifer V Campbell; Sebastian Bonner; Farzana Kapadia; Thelma King Thiel; Steffanie A Strathdee
Journal:  J Hepatol       Date:  2010-11-24       Impact factor: 25.083

8.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

9.  Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis.

Authors:  G Corrao; S Aricò
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

Review 10.  Hepatitis C and alcohol.

Authors:  Eugene R Schiff; Nuri Ozden
Journal:  Alcohol Res Health       Date:  2003
View more
  9 in total

1.  Direct and Indirect Effects of Heavy Alcohol Use on Clinical Outcomes in a Longitudinal Study of HIV Patients on ART.

Authors:  Christopher W Kahler; Tao Liu; Patricia A Cioe; Vaughn Bryant; Megan M Pinkston; Erna M Kojic; Nur Onen; Jason V Baker; John Hammer; John T Brooks; Pragna Patel
Journal:  AIDS Behav       Date:  2017-07

2.  Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Barbara Johnston; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

3.  HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.

Authors:  Jennifer C Elliott; Deborah S Hasin; Malka Stohl; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2016-03

4.  Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial.

Authors:  Christopher W Kahler; David W Pantalone; Nadine R Mastroleo; Tao Liu; Gerald Bove; Bharat Ramratnam; Peter M Monti; Kenneth H Mayer
Journal:  J Consult Clin Psychol       Date:  2018-08

Review 5.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

6.  Reasons for drinking as predictors of alcohol involvement one year later among HIV-infected individuals with and without hepatitis C.

Authors:  Jennifer C Elliott; Malka Stohl; Efrat Aharonovich; Ann O'Leary; Deborah S Hasin
Journal:  Ann Med       Date:  2016-07-27       Impact factor: 4.709

7.  Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Authors:  Milensu Shanyinde; Enrico Girardi; Massimo Puoti; Andrea De Luca; Laura Sighinolfi; Uberti Foppa Caterina; Pietro Caramello; Fiona C Lampe; Antonella D'Arminio Monforte; Alessandro Cozzi-Lepri
Journal:  BMC Public Health       Date:  2019-10-15       Impact factor: 3.295

8.  Heavy Drinking and Treatment among HIV/HCV Co-Infected Patients.

Authors:  Jennifer C Elliott; Noga Shalev; Deborah S Hasin
Journal:  J Subst Abus Alcohol       Date:  2018-07-26

9.  Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study.

Authors:  Ni Gusti Ayu Nanditha; Adrianna Paiero; Hiwot M Tafessu; Martin St-Jean; Taylor McLinden; Amy C Justice; Jacek Kopec; Julio S G Montaner; Robert S Hogg; Viviane D Lima
Journal:  BMJ Open       Date:  2021-01-08       Impact factor: 3.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.